DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)
CUSIP: 25253X207
Q1 2019 13F Holders as of 31 Mar 2019
- Type / Class
- Equity / Voting Common Shares, no par value
- Shares outstanding
- 52,272,727
- Total 13F shares
- 1,013,152
- Share change
- -19,410
- Total reported value
- $4,601,000
- Price per share
- $4.54
- Number of holders
- 10
- Value change
- +$283,018
- Number of buys
- 7
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 25253X207?
CUSIP 25253X207 identifies DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 25253X207:
Top shareholders of DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WEXFORD CAPITAL LP |
13F
|
Company |
0.91%
|
475,000
|
$1,382,000 | — | 31 Dec 2018 | |
| G2 Investment Partners Management LLC |
13F
|
Company |
0.42%
|
219,973
|
$640,000 | — | 31 Dec 2018 | |
| Manatuck Hill Partners, LLC |
13F
|
Company |
0.38%
|
200,000
|
$582,000 | — | 31 Dec 2018 | |
| Worth Venture Partners, LLC |
13F
|
Company |
0.25%
|
129,863
|
$377,000 | — | 31 Dec 2018 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
5,900
|
$17,000 | — | 31 Dec 2018 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,323
|
$4,000 | — | 31 Dec 2018 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
503
|
$1,000 | — | 31 Dec 2018 |
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q1 2019
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2019 vs Q4 2018 Across Filers
| Investor | Q4 2018 Shares | Q1 2019 Shares | Share Diff | Share Chg % | Q4 2018 Value $ | Q1 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.